Product Information

TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3231 per EA under NDC 65862097703. Its NADAC has been published 441 times since Mar 14, 2018.

FDA first approved this application on Dec 15, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB

Telmisartan and Hydrochlorothiazide
$0.3231per EA

Strength

12.5; 80 mg/1; mg/1

NDC

65862097703

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208727

FDA Approved

12/15/2016

TE Code

AB

On Market Since

12/15/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB has been published 441 times since Mar 14, 2018, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3231 per EA
All-time high$1.8612 (May 16, 2018)
All-time low$0.3231 (Aug 19, 2026)
52-week high$0.4121
52-week low$0.3231
Median price$0.9717
Average price$0.9933
Largest weekly change+59.1% (Dec 20, 2023)
Weeks tracked441
Tracking sinceMar 14, 2018

Price History

1W

-4.3%

1M

-4.3%

3M

-6.8%

6M

-1.3%

1Y

-21.6%

3Y

-47.2%

5Y

-75.2%

All

-79.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB, manufactured by Aurobindo Pharma Limited, is $0.3231 per EA (NDC 65862097703), effective Aug 19, 2026.

How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB changed over time?

Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB has declined 79.4%. It has been tracked across 441 weekly CMS publications since Mar 14, 2018.

What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?

Since Mar 14, 2018, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB has ranged from a low of $0.3231 (Aug 19, 2026) to a high of $1.8612 (May 16, 2018), with a median of $0.9717 per EA.

Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?

TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB (NDC 65862097703) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.